Efficacy and safety of linagliptin in type 2 diabetes subjects at high risk for renal and cardiovascular disease: a pooled analysis of six phase III clinical trials

BACKGROUND: In patients with type 2 diabetes mellitus (T2DM), hypertension and microalbuminuria are predictive markers for increased renal and cardiovascular risk. This post hoc analysis of data from a global development program aimed to evaluate the efficacy and safety of linagliptin in a populatio...

Descripción completa

Detalles Bibliográficos
Autores principales: von Eynatten, Maximilian, Gong, Yan, Emser, Angela, Woerle, Hans-Juergen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626685/
https://www.ncbi.nlm.nih.gov/pubmed/23570327
http://dx.doi.org/10.1186/1475-2840-12-60

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626685/
https://www.ncbi.nlm.nih.gov/pubmed/23570327
http://dx.doi.org/10.1186/1475-2840-12-60

Ejemplares similares